Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
sovilnesib (AMG 650) / Volastra Therap
NCT04293094: Study of AMG 650 in Adult Participants With Advanced Solid Tumors	Completed	1	66	Europe, Canada, Japan, US, RoW	AMG 650	Volastra Therapeutics, Inc., Amgen	Advanced Solid Tumors	10/22	02/23
NCT06084416: A Study of Sovilnesib in Subjects With Ovarian Cancer	Recruiting	1	120	US	Sovilnesib	Volastra Therapeutics, Inc.	High Grade Serous Adenocarcinoma of Ovary, Fallopian Tube Cancer, Primary Peritoneal Carcinoma, Chromosomal Instability	03/25	07/25